Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Dearen Danny L.. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Dearen Danny L. har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
Director | 11 247 | |
US:AXNX / Axonics, Inc. | President & CFO | 39 235 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Dearen Danny L.. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Dearen Danny L. som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-18 |
|
4 | BBNX |
Beta Bionics, Inc.
Common Stock |
A - Award | 11 247 | 11 247 | |||||
2023-10-03 |
|
4/A | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | −947 | 39 235 | −2,36 | 49,03 | −46 436 | 1 923 876 | |
2023-10-03 |
|
4/A | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | −17 737 | 40 182 | −30,62 | 48,21 | −855 106 | 1 937 186 | |
2023-10-03 |
|
4/A | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 36 919 | 57 919 | 175,80 | ||||
2023-10-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | −7 675 | 23 777 | −24,40 | 56,87 | −436 490 | 1 352 238 | |
2023-10-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 11 250 | 31 452 | 55,69 | ||||
2023-05-31 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −300 | 9 202 | −3,16 | 50,14 | −15 042 | 461 388 |
2023-05-31 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −7 699 | 9 502 | −44,76 | 49,44 | −380 604 | 469 736 |
2023-04-25 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −9 637 | 17 201 | −35,91 | 60,50 | −583 074 | 1 040 724 |
2023-04-25 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −10 363 | 26 838 | −27,86 | 59,93 | −621 063 | 1 608 423 |
2023-04-25 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 13 208 | 37 201 | 55,05 | 14,19 | 187 422 | 527 882 | |
2023-04-24 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −2 001 | 23 993 | −7,70 | 60,01 | −120 073 | 1 439 731 |
2023-04-24 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 2 001 | 25 994 | 8,34 | 14,19 | 28 394 | 368 855 | |
2023-04-04 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −7 802 | 23 993 | −24,54 | 55,68 | −434 404 | 1 335 894 |
2023-04-04 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −7 198 | 31 795 | −18,46 | 54,83 | −394 699 | 1 743 466 |
2023-04-04 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 2 899 | 38 993 | 8,03 | 1,63 | 4 725 | 63 559 | |
2023-04-04 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 5 468 | 36 094 | 17,85 | 25,82 | 141 184 | 931 947 | |
2023-04-04 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 6 633 | 30 626 | 27,65 | 14,19 | 94 122 | 434 583 | |
2023-02-02 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | −2 772 | 23 993 | −10,36 | 61,02 | −169 136 | 1 463 957 | |
2023-02-02 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | −474 | 26 765 | −1,74 | 60,43 | −28 646 | 1 617 535 | |
2023-02-02 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | −2 720 | 27 239 | −9,08 | 61,12 | −166 252 | 1 664 899 | |
2023-02-02 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | −7 791 | 29 959 | −20,64 | 61,17 | −476 571 | 1 832 574 | |
2023-02-02 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 25 250 | 37 750 | 202,00 | ||||
2023-02-02 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
A - Award | 5 000 | 12 500 | 66,67 | ||||
2022-09-15 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −656 | 7 500 | −8,04 | 75,60 | −49 594 | 567 000 |
2022-08-15 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −6 960 | 8 156 | −46,04 | 72,19 | −502 429 | 588 766 |
2022-08-15 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −16 280 | 15 116 | −51,85 | 71,26 | −1 160 173 | 1 077 222 |
2022-08-15 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −26 760 | 31 396 | −46,01 | 70,33 | −1 881 921 | 2 207 952 |
2022-08-15 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 6 250 | 58 156 | 12,04 | 25,82 | 161 375 | 1 501 588 | |
2022-08-15 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 7 047 | 51 906 | 15,71 | 14,19 | 99 997 | 736 546 | |
2022-08-15 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 20 545 | 44 859 | 84,50 | 1,63 | 33 488 | 73 120 | |
2022-08-15 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 2 044 | 24 314 | 9,18 | 1,32 | 2 698 | 32 094 | |
2022-08-15 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 1 616 | 22 270 | 7,82 | 1,32 | 2 133 | 29 396 | |
2022-03-03 |
|
4 | AXNX |
Axonics, Inc.
Stock Options (Right to buy) |
M - Exercise | −12 329 | 2 343 | −84,03 | ||||
2022-03-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −10 564 | 20 654 | −33,84 | 58,11 | −613 913 | 1 200 280 |
2022-03-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −7 846 | 31 218 | −20,08 | 57,40 | −450 321 | 1 791 757 |
2022-03-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −1 500 | 39 064 | −3,70 | 56,32 | −84 475 | 2 199 952 |
2022-03-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 12 329 | 40 564 | 43,67 | 25,82 | 318 335 | 1 047 362 | |
2022-03-01 |
|
4 | AXNX |
Axonics, Inc.
Stock Options (Right to buy) |
M - Exercise | −3 579 | 6 666 | −34,93 | ||||
2022-03-01 |
|
4 | AXNX |
Axonics, Inc.
Stock Options (Right to buy) |
M - Exercise | −6 421 | 14 672 | −30,44 | ||||
2022-03-01 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −10 000 | 28 235 | −26,15 | 57,00 | −570 000 | 1 609 395 |
2022-03-01 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 3 579 | 38 235 | 10,33 | 14,19 | 50 786 | 542 555 | |
2022-03-01 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 6 421 | 34 656 | 22,74 | 25,82 | 165 790 | 894 818 | |
2022-02-03 |
|
4 | AXNX |
Axonics, Inc.
Performance-Based Restricted Stock Units |
M - Exercise | −26 086 | 0 | −100,00 | ||||
2022-02-03 |
|
4 | AXNX |
Axonics, Inc.
Performance-Based Restricted Stock Units |
M - Exercise | −10 833 | 0 | −100,00 | ||||
2022-02-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | −947 | 28 235 | −3,25 | 49,03 | −46 436 | 1 384 495 | |
2022-02-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | −17 737 | 29 182 | −37,80 | 48,21 | −855 106 | 1 406 873 | |
2022-02-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 36 919 | 46 919 | 369,19 | ||||
2022-02-03 |
|
4 | AXNX |
Axonics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −20 000 | 32 468 | −38,12 | ||||
2022-02-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −400 | 10 000 | −3,85 | 49,70 | −19 878 | 496 950 |
2022-02-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −13 853 | 10 400 | −57,12 | 49,07 | −679 718 | 510 292 |
2022-02-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −3 730 | 24 253 | −13,33 | 48,26 | −179 999 | 1 170 382 |
2022-02-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −2 017 | 27 983 | −6,72 | 46,83 | −94 452 | 1 310 388 |
2022-02-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 20 000 | 30 000 | 200,00 | 14,19 | 283 800 | 425 700 | |
2022-02-03 |
|
4 | AXNX |
Axonics, Inc.
Performance-Based Restricted Stock Units |
A - Award | 5 250 | 5 250 | |||||
2022-02-03 |
|
4 | AXNX |
Axonics, Inc.
Performance-Based Restricted Stock Units |
A - Award | 5 250 | 5 250 | |||||
2022-02-03 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
A - Award | 11 000 | 21 000 | 110,00 | ||||
2022-01-20 |
|
4 | AXNX |
Axonics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −3 718 | 0 | −100,00 | ||||
2022-01-20 |
|
4 | AXNX |
Axonics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −5 477 | 23 444 | −18,94 | ||||
2022-01-20 |
|
4 | AXNX |
Axonics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 805 | 52 468 | −17,08 | ||||
2022-01-20 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −2 046 | 10 000 | −16,98 | 52,61 | −107 632 | 526 063 |
2022-01-20 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −3 886 | 12 046 | −24,39 | 51,68 | −200 832 | 622 549 |
2022-01-20 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −9 756 | 15 932 | −37,98 | 50,80 | −495 648 | 809 416 |
2022-01-20 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −4 312 | 25 688 | −14,37 | 49,73 | −214 428 | 1 277 415 |
2022-01-20 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 3 718 | 30 000 | 14,15 | 1,42 | 5 280 | 42 600 | |
2022-01-20 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 5 477 | 26 282 | 26,33 | 1,63 | 8 928 | 42 840 | |
2022-01-20 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 10 805 | 20 805 | 108,05 | 14,19 | 153 323 | 295 223 | |
2021-05-24 |
|
4 | AXNX |
Axonics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −5 875 | 28 921 | −16,88 | ||||
2021-05-24 |
|
4 | AXNX |
Axonics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −991 | 10 934 | −8,31 | ||||
2021-05-24 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −6 866 | 10 000 | −40,71 | 55,22 | −379 164 | 552 234 |
2021-05-24 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 5 875 | 16 866 | 53,45 | 1,63 | 9 576 | 27 492 | |
2021-05-24 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 991 | 10 991 | 9,91 | 1,32 | 1 308 | 14 508 | |
2021-05-24 |
|
4 | AXNX |
Axonics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −5 142 | 11 925 | −30,13 | ||||
2021-05-24 |
|
4 | AXNX |
Axonics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −9 701 | 1 616 | −85,72 | ||||
2021-05-24 |
|
4 | AXNX |
Axonics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −28 291 | 63 273 | −30,90 | ||||
2021-05-24 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −24 618 | 10 000 | −71,11 | 55,05 | −1 355 135 | 550 465 |
2021-05-24 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −18 516 | 34 618 | −34,85 | 54,45 | −1 008 265 | 1 885 078 |
2021-05-24 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 5 142 | 53 134 | 10,71 | 1,32 | 6 787 | 70 137 | |
2021-05-24 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 9 701 | 47 992 | 25,33 | 1,32 | 12 805 | 63 349 | |
2021-05-24 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 28 291 | 38 291 | 282,91 | 14,19 | 401 449 | 543 349 | |
2021-04-23 |
|
4 | AXNX |
Axonics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −15 103 | 91 564 | −14,16 | ||||
2021-04-23 |
|
4 | AXNX |
Axonics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −9 897 | 3 718 | −72,69 | ||||
2021-04-23 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −8 046 | 10 000 | −44,59 | 62,15 | −500 056 | 621 497 |
2021-04-23 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −14 382 | 18 046 | −44,35 | 61,58 | −885 694 | 1 111 336 |
2021-04-23 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −2 572 | 32 428 | −7,35 | 60,30 | −155 082 | 1 955 292 |
2021-04-23 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 15 103 | 35 000 | 75,91 | 14,19 | 214 312 | 496 650 | |
2021-04-23 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 9 897 | 19 897 | 98,97 | 1,42 | 14 054 | 28 254 | |
2021-04-23 |
|
4 | AXNX |
Axonics, Inc.
Stock Option (Right to Buy) |
M - Exercise | −1 265 | 13 615 | −8,50 | ||||
2021-04-23 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −1 769 | 10 000 | −15,03 | 58,61 | −103 688 | 586 141 |
2021-04-23 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
S - Sale | X | −73 231 | 11 769 | −86,15 | 58,14 | −4 257 731 | 684 263 |
2021-04-23 |
|
4 | AXNX |
Axonics, Inc.
Common Stock |
M - Exercise | 1 265 | 85 000 | 1,51 | 1,42 | 1 796 | 120 700 | |
2021-02-02 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Performance-Based Restricted Stock Units |
M - Exercise | −8 000 | 0 | −100,00 | ||||
2021-02-02 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | −507 | 83 735 | −0,60 | 52,12 | −26 424 | 4 364 092 | |
2021-02-02 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | −6 751 | 84 242 | −7,42 | 51,36 | −346 762 | 4 327 048 | |
2021-02-02 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 16 000 | 90 993 | 21,34 | ||||
2021-02-02 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Performance-Based Restricted Stock Units |
A - Award | 10 000 | 10 000 | |||||
2021-02-02 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Performance-Based Restricted Stock Units |
A - Award | 10 833 | 10 833 | |||||
2021-02-02 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
A - Award | 10 000 | 74 993 | 15,39 | ||||
2021-01-27 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Performance-Based Restricted Stock Units |
M - Exercise | −13 043 | 0 | −100,00 | ||||
2021-01-27 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | −4 541 | 64 993 | −6,53 | 53,58 | −243 291 | 3 482 104 | |
2021-01-27 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 13 043 | 69 534 | 23,09 | ||||
2020-07-09 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −709 | 34 796 | −2,00 | ||||
2020-07-09 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −709 | 56 491 | −1,24 | 40,00 | −28 360 | 2 259 640 |
2020-07-09 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 709 | 57 200 | 1,26 | 1,63 | 1 156 | 93 236 | |
2020-06-22 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −8 890 | 8 177 | −52,09 | ||||
2020-06-22 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −2 015 | 14 880 | −11,93 | ||||
2020-06-22 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −34 095 | 35 505 | −48,99 | ||||
2020-06-22 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −45 000 | 56 491 | −44,34 | 38,11 | −1 714 977 | 2 152 906 |
2020-06-22 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 34 095 | 101 491 | 50,59 | 1,63 | 55 575 | 165 430 | |
2020-06-22 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 8 890 | 67 396 | 15,20 | 1,32 | 11 735 | 88 963 | |
2020-06-22 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 2 015 | 58 506 | 3,57 | 1,42 | 2 861 | 83 079 | |
2020-06-22 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −2 251 | 17 067 | −11,65 | ||||
2020-06-22 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −27 749 | 16 895 | −62,16 | ||||
2020-06-22 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −30 000 | 56 491 | −34,69 | 39,26 | −1 177 881 | 2 217 989 |
2020-06-22 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 2 251 | 86 491 | 2,67 | 1,32 | 2 971 | 114 168 | |
2020-06-22 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 27 749 | 84 240 | 49,12 | 1,42 | 39 404 | 119 621 | |
2020-05-19 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −5 222 | 19 318 | −21,28 | ||||
2020-05-19 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −9 778 | 11 317 | −46,35 | ||||
2020-05-19 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −15 000 | 56 491 | −20,98 | 40,05 | −600 777 | 2 262 566 |
2020-05-19 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 15 000 | 71 491 | 26,55 | 1,32 | 19 800 | 94 368 | |
2020-05-19 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −15 000 | 21 095 | −41,56 | ||||
2020-05-19 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −15 000 | 56 491 | −20,98 | 37,26 | −558 842 | 2 104 634 |
2020-05-19 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 15 000 | 71 491 | 26,55 | 1,32 | 19 800 | 94 368 | |
2020-05-19 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −2 722 | 36 095 | −7,01 | ||||
2020-05-19 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −27 278 | 0 | −100,00 | ||||
2020-05-19 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −15 000 | 56 491 | −20,98 | 35,24 | −528 550 | 1 990 556 |
2020-05-19 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −15 000 | 71 491 | −17,34 | 35,03 | −525 442 | 2 504 294 |
2020-05-19 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 27 278 | 86 491 | 46,07 | 0,98 | 26 732 | 84 761 | |
2020-05-19 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 2 722 | 59 213 | 4,82 | 1,32 | 3 593 | 78 161 | |
2020-05-14 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −20 000 | 27 278 | −42,30 | ||||
2020-05-14 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | −129 | 56 491 | −0,23 | 34,53 | −4 454 | 1 950 634 | |
2020-05-14 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −19 871 | 56 620 | −25,98 | 34,18 | −679 252 | 1 935 447 |
2020-05-14 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 20 000 | 76 491 | 35,40 | 0,98 | 19 600 | 74 961 | |
2020-05-14 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −15 000 | 47 278 | −24,09 | ||||
2020-05-14 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −15 000 | 47 278 | −24,09 | ||||
2020-05-14 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −15 000 | 56 491 | −20,98 | 35,02 | −525 270 | 1 978 202 |
2020-05-14 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −1 900 | 71 491 | −2,59 | 34,22 | −65 013 | 2 446 222 |
2020-05-14 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −13 100 | 73 391 | −15,15 | 34,78 | −455 660 | 2 552 774 |
2020-05-14 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 15 000 | 86 491 | 20,98 | 0,98 | 14 700 | 84 761 | |
2020-05-14 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 15 000 | 86 491 | 20,98 | 0,98 | 14 700 | 84 761 | |
2020-05-14 |
|
4/A | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −4 147 | 77 278 | −5,09 | ||||
2020-05-14 |
|
4/A | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −4 147 | 56 491 | −6,84 | 37,00 | −153 439 | 2 090 167 |
2020-05-14 |
|
4/A | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 4 147 | 60 638 | 7,34 | 0,98 | 4 064 | 59 425 | |
2020-05-14 |
|
4/A | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −15 853 | 81 425 | −16,30 | ||||
2020-05-14 |
|
4/A | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −7 853 | 56 491 | −12,20 | 37,01 | −290 613 | 2 090 540 |
2020-05-14 |
|
4/A | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −8 000 | 64 344 | −11,06 | 37,01 | −296 062 | 2 381 223 |
2020-05-14 |
|
4/A | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 15 853 | 72 344 | 28,06 | 0,98 | 15 536 | 70 897 | |
2020-05-14 |
|
4/A | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −20 000 | 56 491 | −26,15 | 34,25 | −685 000 | 1 934 817 |
2020-05-14 |
|
4/A | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −20 103 | 97 278 | −17,13 | ||||
2020-05-14 |
|
4/A | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −103 | 76 491 | −0,13 | 34,00 | −3 502 | 2 600 694 |
2020-05-14 |
|
4/A | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 20 103 | 76 594 | 35,59 | ||||
2020-05-14 |
|
4/A | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −20 000 | 117 381 | −14,56 | ||||
2020-05-14 |
|
4/A | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −20 000 | 48 491 | −29,20 | 31,46 | −629 156 | 1 525 420 |
2020-05-14 |
|
4/A | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 20 000 | 68 491 | 41,24 | ||||
2020-03-04 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −4 147 | 125 234 | −3,21 | ||||
2020-03-04 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | −4 147 | 8 535 | −32,70 | 37,00 | −153 439 | 315 795 | |
2020-03-04 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 4 147 | 12 682 | 48,59 | 0,98 | 4 064 | 12 428 | |
2020-02-28 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
M - Exercise | −8 000 | 129 381 | −5,82 | ||||
2020-02-28 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −7 853 | 8 535 | −47,92 | 37,01 | −290 613 | 315 851 |
2020-02-28 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −8 000 | 16 388 | −32,80 | 37,01 | −296 062 | 606 482 |
2020-02-28 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 8 000 | 24 388 | 48,82 | 0,98 | 7 840 | 23 900 | |
2020-02-18 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −20 000 | 16 388 | −54,96 | 34,25 | −685 000 | 561 289 |
2020-02-18 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −103 | 36 388 | −0,28 | 34,00 | −3 502 | 1 237 192 |
2020-02-03 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Performance-Based Restricted Stock Units |
M - Exercise | −8 000 | 0 | −100,00 | ||||
2020-02-03 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
M - Exercise | 8 000 | 36 491 | 28,08 | ||||
2020-01-27 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −20 000 | 28 491 | −41,24 | 31,46 | −629 156 | 896 264 |
2019-12-23 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −30 000 | 48 491 | −38,22 | 26,07 | −782 109 | 1 264 175 |
2019-12-16 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
A - Award | 37 500 | 37 500 | |||||
2019-12-16 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Performance-Based Restricted Stock Units |
A - Award | 13 043 | 13 043 | |||||
2019-12-16 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Performance-Based Restricted Stock Units |
A - Award | 13 043 | 13 043 | |||||
2019-11-25 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | X | −30 000 | 78 491 | −27,65 | 21,61 | −648 225 | 1 695 994 |
2019-11-21 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
S - Sale | −30 000 | 108 491 | −21,66 | 20,74 | −622 050 | 2 249 561 | |
2019-02-01 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Performance-Based Restricted Stock Units |
A - Award | 8 000 | 8 000 | |||||
2019-02-01 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Performance-Based Restricted Stock Units |
A - Award | 8 000 | 8 000 | |||||
2019-02-01 |
|
4 | AXNX |
Axonics Modulation Technologies, Inc.
Stock Option (Right to Buy) |
A - Award | 106 667 | 106 667 | |||||
2018-10-30 | 3 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
276 982 | ||||||||
2018-10-30 | 3 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
276 982 | ||||||||
2018-10-30 | 3 | AXNX |
Axonics Modulation Technologies, Inc.
Common Stock |
276 982 |